Rhabdoviruses are a family of enveloped RNA viruses that can infect various hosts, including animals, plants, and insects. One well-known member of this family is the rabies virus, which causes the severe and often fatal disease known as rabies. Rhabdoviruses have a bullet-shaped morphology and a single-stranded, negative-sense RNA genome. They enter host cells by binding to specific receptors and are known for their ability to cause a wide range of diseases in different species. The rabies virus, transmitted through the saliva of infected animals, primarily affects mammals, including humans. Once symptoms appear, rabies is almost universally fatal if not treated promptly. Research on rhabdoviruses extends beyond their medical significance, as some members of this family also serve as valuable tools in molecular biology and gene expression studies. The study of rhabdoviruses continues to contribute to our understanding of viral pathogenesis, vaccine development, and antiviral strategies.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States